CLINICAL_TRIALS
trial_result
· 2019-05-28
Clinical Trial Update: Repurposing alpha1 Noradrenergic Antagonists for Alcoholism Treatment [Phase 1, Phase 2]
Summary
A completed Phase 1/Phase 2 clinical trial exploring repurposing alpha1-adrenergic antagonists for alcoholism treatment.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Wisconsin, Madison | Conditions: Alcoholism | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-05-28